abstract

Enteroaggregative Escherichia coli (EAEC) is emerging as a significant diarrheal pathogen in multiple population groups. Although most commonly associated with pediatric diarrhea in developing countries, EAEC is also linked to diarrhea in adults including HIV‐positive patients and travelers and has been a cause of food‐borne outbreaks in the industrialized world. Current data suggest that one set of virulence elements is not associated with all EAEC strains, but that combinations of multiple factors prevail. Pathogenesis is believed to be initiated with adherence to the terminal ileum and colon in an aggregative, stacked‐brick‐type pattern by means of one of several different hydrophobic aggregative adherence fimbriae. Some strains of EAEC may then elaborate cytotoxins including the plasmid‐encoded toxin and the enterotoxins, EAST1 and ShET1. An AraC homolog termed AggR regulates several genes contributing to fimbrial biogenesis in ‘typical EAEC strains’. AggR has now also been shown to regulate genes on a chromosomal island. Sequencing of the EAEC type strain 042 completed at the Sanger Center has revealed two other chromosomal islands that are being explored for their pathogenetic potential. This article reviews these virulence elements and presents on‐going areas of research in EAEC pathogenesis.

Introduction

The majority of Escherichia coli are harmless commensals of the mammalian gastrointestinal tract, yet some strains have deviated from this ancestral niche, adapting specific virulence traits that enable them to cause disease in otherwise healthy individuals. The resulting clinical syndromes may include gastroenteritis, urinary tract infection, septicemia and meningitis. Escherichia coli enteritis may itself be caused by at least six distinct E. coli pathotypes: enterotoxigenic (ETEC), enteropathogenic (EPEC), enterohemorrhagic (EHEC), enteroinvasive (EIEC), diffusely adherent (DAEC) and enteroaggregative E. coli (EAEC). These pathotypes exhibit distinct clinical, epidemiologic and pathogenic profiles. Strains within each pathotype are characterized by shared virulence traits and can typically be further distinguished by O (lipopolysaccharide) and H (flagellar) antigens (Kaper , 2004).

EAEC was first described in 1985, recognized by its distinctive adherence to HEp‐2 cells in an aggregative, stacked brick‐like pattern. This adherence pattern, distinguishable from the adherence patterns manifested by EPEC and DAEC, was first significantly associated with diarrhea among children in Santiago, Chile in 1987 (Nataro , 1987). Laboratory studies on prototype strains revealed that the aggregative adherence (AA) phenotype was encoded on 55–65 MDa plasmids, collectively called pAA (Vial , 1988). In a subsequent report, a cryptic fragment of the plasmid was found to be useful as a specific and variably sensitive DNA probe, which could distinguish EAEC from other E. coli (Baudry , 1990). Many epidemiologic studies now use the AA phenotype and the plasmid‐encoded probe (termed CVD 432 or simply the AA probe) to identify EAEC (Huppertz , 1997; Germani , 1998; Okeke , 2003). Although the probe only identifies a fraction of strains that exhibit the AA adherence pattern, epidemiologic and pathogenetic studies suggest that these strains may be the true EAEC pathogens.

Since its discovery, an increasing number of studies have implicated EAEC in diarrhea in a variety of settings. These now include endemic diarrhea of infants in both industrialized and developing countries (reviewed in Okeke & Nataro, 2001; Huang & DuPont, 2004; Huang , 2004), persistent diarrhea among human immunodeficiency virus/acquired immunodeficiency syndrome patients and traveler's diarrhea. Several outbreaks of EAEC diarrhea have also been described. Prospective studies suggest that in well‐nourished populations in industrialized countries, EAEC may be a cause of endemic sporadic diarrhea. For example, a large prospective surveillance study in the UK implicated EAEC among the major pathogens at all ages (Wilson , 2001).

The implication of EAEC in diarrheal outbreaks confirmed the fact that at least some strains exhibiting the AA phenotype were true human pathogens, yet in not all studies were EAEC significantly associated with diarrheal illness. Much recent work focuses on identifying required virulence genes to better identify the true EAEC pathogens.

The clinical presentation of EAEC infection comprises watery diarrhea, occasionally with blood and mucus. Several studies have suggested that patients infected with EAEC manifest intestinal inflammation, marked by the presence of fecal lactoferrin and proinflammatory cytokines, notably interleukin (IL)‐8 (Steiner , 1998; Greenberg , 2002). Steiner (1998) have suggested that even asymptomatic carriage of EAEC strains can result in evidence of low‐level enteritis.

Pathogenesis studies of EAEC experienced a breakthrough in 1994, when the senior author published the first EAEC volunteer study (Nataro , 1995). In this report, we showed that only one of four AA probe positive EAEC strains elicited human diarrhea, confirming that not all EAEC strains were equally pathogenic. Investigations since that time in our laboratory have utilized strain 042, which elicited diarrhea in the majority of volunteers. Pathogenesis studies have suggested three major features of EAEC pathogenesis (Fig. 1): (1) abundant adherence to the intestinal mucosa, (2) elaboration of enterotoxins and cytotoxins, and (3) induction of mucosal inflammation. Evidence for each of these features is discussed below.

1

  The basic features of enteroaggregative Escherichia coli pathogenesis. AAF, aggregative adherence fimbria. See text for discussion.

1

  The basic features of enteroaggregative Escherichia coli pathogenesis. AAF, aggregative adherence fimbria. See text for discussion.

Tissue pathology

Studies using explants of viable colonic tissue harvested during intestinal biopsy suggest that EAEC adheres to both human ileal and colonic tissues (Knutton , 1992; Hicks , 1996). EAEC is adherent to intestinal tissues in an aggregative manner in association with a thick mucus layer (Tzipori , 1992; Hicks , 1996). Adherence is followed by mucosal toxicity, including crypt dilation, microvillous vesiculation, and epithelial cell extrusion (Fig. 2) (Hicks , 1996; Nataro , 1996). This histopathology has not yet been observed in natural human infections. Notably, no polymorphonuclear cell infiltrate has been reported for EAEC infection (Vial , 1988).

2

  Transmission electron micrograph showing interaction of enteroaggregative Escherichia coli with T84 cell monolayers. Note the adherent bacteria, lack of microvilli, ballooning of the apical cytoplasm, vacuolization and membrane vesiculation. (From Nataro et al., 1998, with permission.)

2

  Transmission electron micrograph showing interaction of enteroaggregative Escherichia coli with T84 cell monolayers. Note the adherent bacteria, lack of microvilli, ballooning of the apical cytoplasm, vacuolization and membrane vesiculation. (From Nataro et al., 1998, with permission.)

Virulence factors mediating pathogenesis

Adhesins and other plasmid‐encoded virulence factors

Cloning of the factor mediating the AA phenotype in prototype strain 17‐2 revealed the presence of bundle‐forming fimbriae termed aggregative adherence fimbria (AAF) (Nataro , 1992). The AAF conferred the AA phenotype on E. coli K12 strains, along with strong hemagglutination of human erythrocytes. Genes required for biogenesis of the AAF were found to be localized on the pAA plasmid of this strain. However, the strain that caused disease in volunteers, 042, was found to be nonreactive to gene probes derived from the AAF operon, and we subsequently reported that this strain adheres to the human colonic mucosa by virtue of a distinct allele, termed AAF/II (the fimbriae of 17‐2 were renamed AAF/I) (Nataro , 1995). Importantly, the major pilin subunit of AAF/II (called AafA) exhibited less than 25% amino acid identity with the major pilin of AAF/I (Czeczulin , 1997). Since the description of AAF/II, three other allelic variants have been described (Nataro , 1992; Czeczulin , 1997; Bernier , 2002), and notably, some strains manifest the AA phenotype, but do not harbor any of the known fimbriae, suggesting the presence of additional adhesins not yet characterized (Czeczulin , 1997; Bernier , 2002). Nonfimbrial adhesins are also likely (Monteiro‐Neto , 2003). It is important to note that in almost all cases, a particular EAEC strain expresses only one of the possible AAF alleles. Thus, like ETEC, EAEC apparently adheres and colonizes by virtue of antigenically heterogeneous adhesins, which will hamper any efforts to develop immunologic prophylaxis strategies.

The AAF biogenesis genes feature an organization similar to genes of the Dr family of fimbrial adhesins, which are adhesins of uropathogenic E. coli and DEAC (Bilge , 1989; Savarino , 1994; Elias , 1999; Bernier , 2002). In fact, the accessory genes of the Dr family are more closely related (30–70% amino acid identity) to those of the AAFs than are the major AAF pilin subunits to each other. In addition to the usher and chaperone proteins that are required for assembly of the Dr structures, AAFs also include a gene that has been suggested to encode a minor pilin subunit (aafB), which may mediate epithelial cell invasion (Bernier & Le Bouguenec, 2002). Some investigators have suggested that EAEC may be an invasive pathogen, but proven pathogenic strain 042 is notably noninvasive in in vitro studies.

Expression of AAF genes requires AggR, a transcriptional activator of the AraC class (Nataro , 1994). This protein regulates the genes involved in fimbrial biogenesis for both AAF/I and AAF/II. Genomic studies of the pAA plasmid revealed a small open reading frame (ORF) just upstream of the aggR gene in most EAEC strains. This gene was found to encode a 10 kDa secreted protein that was recognized by the sera of volunteers fed strain 042. A null mutant of this gene revealed a unique hyperaggregative phenotype, and scanning electron microscopy of the bacterial strains showed collapse of the AAF fimbriae onto the bacterial cell surface. The protein product of this gene was therefore termed antiaggregation protein (Aap), nicknamed dispersin (Sheikh , 2002). Dispersin is secreted to the surface of EAEC strains and binds noncovalently to the lipopolysaccharide (LPS) of the outer membrane. Recent data suggest that the mechanism of dispersin's effect may be mediated predominantly through its ability to neutralize the strong negative charge of the LPS, so that the AAFs, which carry a strong positive charge, are free to splay out from the surface and bind distant sites (J. Velarde, unpublished). Interestingly, the secretion of dispersin is dependent on the presence of an ABC transporter complex also encoded on plasmid pAA (Nishi , 2003). The genes encoding this transporter (the Aat complex) correspond to the site of the previously cryptic AA probe. As both dispersin and the Aat complex are under the control of AggR, the latter protein is emerging as the central regulator of virulence functions in EAEC. In recognition of this fact, we have begun to use the term typical EAEC to refer to strains that carry the AggR regulon.

The AggR regulon is not restricted to the pAA plasmid. Dudley et al. have recently found that in addition to these plasmid‐encoded genes, AggR regulates a chromosomal operon inserted on a pathogenicity island at the pheU locus (E. Dudley and J. Nataro, unpublished).

Toxins

In an effort to identify cytotoxins and enterotoxins, Navarro‐Garcia (1998) analyzed culture supernatants from strains that caused outbreaks of EAEC diarrhea in Mexican hospitals. Two major proteins of 108 and 116 kDa, respectively, were secreted. Both proteins are autotransporter proteins and, thus, undergo two cleavage steps before a functional protein is released into the extracellular space. The passenger domains contain the protease motif (GDSGSP) characteristic of all proteins of the serine protease autotransporter of Enterobacteriaceae (SPATE) group (Henderson , 1998). The 108 kDa protein is termed plasmid‐encoded toxin (Pet) (Eslava , 1998). Strain 042, which expresses Pet, induced dilation of crypt openings and intercrypt crevices and rounding and extrusion of enterocytes in intestinal explants, whereas 042pet did not affect tissue in this way (Henderson , 1999b). Data suggest that the toxic effects of Pet are because of cytoskeletal rearrangements following Pet‐mediated cleavage of the membrane cytoskeletal protein spectrin (Villaseca , 2000; Canizalez‐Roman & Navarro‐Garcia, 2003). Although Pet may play a role in EAEC pathogenesis, it is only present in a minority of strains (Czeczulin , 1999) and was not correlated with damage to T84 enterocytes in culture (Henderson , 1999b).

Rises in short‐circuit current and potential difference have been reported for two other EAEC virulence factors using the Ussing chamber system (World Precision Instruments, Sarasota, FL). The first of these, EAST1, is a plasmid‐encoded enterotoxin with homology to the heat‐stable enterotoxin (STa) of ETEC and the endogenous signaling peptide, guanylin (Savarino , 1993). However, EAST1 is present in only a subset of EAEC and has a broad distribution among other pathogenic and nonpathogenic E. coli (Savarino , 1995; Zhou , 2002).

Chromosomally encoded virulence factors

The third enterotoxin that may contribute to EAEC diarrhea is the chromosomally encoded ShET1. The setBA genes, encoding ShET1, are contained entirely within and antisense to pic, which encodes the 116 kDa secreted protein discovered by Navarro‐Garcia (1998). The setA and setB genes are predicted to encode a holotoxin with an A1 : B5 stoichiometry (Fasano , 1995). ShET1 caused fluid accumulation in the rabbit ligated loop model in addition to activity in the Ussing chamber system. The mechanism mediating ShET1 enterotoxic activity is independent of cyclic adenosine monophosphate, cyclic guanosine monophosphate and Ca++, and may involve signaling through nitric oxide (Fasano , 1997) (A. Fasano, personal communication). While ShET1 is a putative enterotoxin, Pic has mucinolytic and hemagglutinin activities (Henderson , 1999a).

This locus is not unique to EAEC. The pic/setBA genes have also been found in Shigella flexneri 2a (Fasano , 1995) and uropathogenic E. coli (UPEC) CFT 073 (Heimer , 2004) with nucleotide sequence identities of 99% and 96%, respectively, compared with 042. Limited prevalence studies suggest that this locus may play a role in pathogenesis. In EAEC the prevalence of pic/setBA varies between 4.6% and 57% of strains (Czeczulin , 1999; Okeke , 2000; Vila , 2000; Piva , 2003; Sarantuya , 2004) and was associated with diarrhea in Brazilian children and adult travelers from Spain (Vila , 2000; Piva , 2003). In one study, set1A was amplified from 22 of 22 S. flexneri 2a strains tested, and rarely in other Shigella species and serotypes (Noriega , 1995). Heimer (2004) demonstrated a prevalence of pic in 31% of pyelonephritis isolates compared with 7% of fecal strains. However, using the CBA mouse model of ascending urinary tract infection, no colonization advantage was observed.

Basic local alignment search tool analysis of the 042 sequence assembled at the Sanger Center in the UK (http://www.sanger.ac.uk) reveals that pic/setBA resides on the 117 kb pathogenicity island inserted at the pheU tRNA locus (E. Dudley, personal communication). Sequences flanking pic/setBA include insertion sequence (IS) elements IS911 and IS629. An IS‐like orf, perD, and a cryptic prophage gene, L0015, are downstream of pic (Henderson , 1999a). Al‐Hasani (2001) have determined that the pic/setBA locus is contained within a pathogenicity island (PAI) termed she in S. flexneri YSH6000T inserted adjacent to the pheV tRNA gene. The IS elements flanking pic/setBA in EAEC differ from those within the she PAI, suggesting that gene acquisition was distinct for these two species.

Also inserted in the pheU island are gene clusters SciI and SciII that are about 20 kb each, the latter of which is under AggR control (Ed Dudley and J. Nataro, unpublished). SciII comprises a cluster of 16 predicted ORFs, which we have designated as aaiAP (for AggR‐activated island). Molecular studies have revealed an AggR‐dependent promoter upstream of aaiA, and have suggested that these 16 predicted genes may be transcribed as an operon. Except for aaiP, which putatively encodes a ClpB chaperone, no other ORF encodes a protein of well‐defined function. The contribution of the aai genes to EAEC pathogenesis is currently unknown, but these genes do not appear to play a role in adherence to abiotic surfaces or intestinal epithelial cells, as do previously described AggR‐regulated genes.

Other researchers have noted the presence of genes similar to aaiA‐P in other organisms, notably gram‐negative pathogenic and symbiotic bacteria (Folkesson , 2002; Rao , 2004). Rao (2004) identified such a group of genes in the fish pathogen Edwardsiella tarda, and designated them as evpA through evpH. Mutations in evpA or evpB increased the LD50 of E. tarda in blue gourami by nearly 2 log, and abolished the secretion of EvpC. Likewise in EAEC, we have found that AaiC is a secreted protein (E. Dudley and J. Nataro unpublished data). However, while sequence comparison between the EAEC and E. tarda systems identifies multiple orthologs, there is no detectable sequence similarity between EvpC and AaiC. One reasonable hypothesis is that each system encodes related proteins comprising a secretion apparatus, but that these systems secrete unrelated effector proteins, as is well documented with well‐defined secretion systems of gram‐negative bacteria such as the type III secretion system.

As sequencing and annotation of the genome of strain 042 are completed, additional potential virulence factors are being revealed. At least two additional pathogenicity islands are present. One of these, inserted at glyU, encodes a homolog of the ETT‐2‐type III secretion system of 0157:H7. A second island contains genes for a transcriptional regulator and type III effector proteins and is inserted in selC (J. Sheikh and J. Nataro, personal communication). Additionally, the Yersinia high‐pathogenicity island, containing the Yersiniabactin siderophore gene, is present in a majority of strains (Schubert , 1998).

Potential proinflammatory role of EAEC factors

In a search for factors that may be responsible for the inflammatory presentation of EAEC‐infected patients, Steiner (2000) reported that the flagellin of EAEC strains induced the release of IL‐8 from Caco‐2 cells in culture. IL‐8 release was subsequently linked to binding to the Toll‐like receptor 5 on the target epithelium (Hayashi , 2001). Steiner and others have also suggested a role for plasmid‐encoded factors in IL‐8 induction (Steiner , 1998; Jiang , 2002). Jiang (2002) reported that IL‐8 levels were higher in feces of patients infected with aggR‐ or aafA‐containing strains compared with those infected with strains negative for these factors. Recently, it was also shown that EAEC strains harboring aggR, aggA and aap were more likely to cause IL‐8 induction of >100 pg mL−1 from nonpolarized HCT‐8 IECs than EAEC negative for those genes (Huang , 2004). Our laboratory sought to identify additional factors that could account for IL‐8 release from epithelial cells infected with EAEC strain 042. In this study, polarized T84 intestinal cells were found to release IL‐8 even when infected with 042 mutated in the major flagellar subunit FliC. IL‐8 release from polarized T84 cells was found to require the AggR activator and the AAF fimbriae, and IL‐8 release was significantly less when cells were infected with mutants in the minor fimbrial subunit AafB (Harrington , 2005).

The AafB protein had previously been reported to be a homolog of a class of putative invasion proteins in uropathogenic and DEAC (Bernier & Le Bouguenec, 2002; Plancon , 2003; Cota , 2004). Plancon (2003) have suggested that the invasion phenotype may involve binding to β1 integrins on the cell surface. Further characterization of the role of the AAF adhesin and its subunits in inflammation is clearly warranted.

Gene regulation in EAEC

The central role of AggR in coordination of EAEC virulence genes confers a strong priority to understand how the expression of this protein is itself regulated. Recent studies in the authors' laboratory have revealed that AggR is essential for its own expression. The protein binds to a specific binding site in the vicinity of the promoter −35 site. A second AggR binding site is suggested by DNA footprinting, though no role for a second site can be shown in gene expression studies (R. Sohoni and J. Nataro unpublished observations). The presence of essential autoactivation raises the important question: how is aggR expression initiated and terminated, in light of the fact that the AggR regulon is preferentially expressed in logarithmic phase and in rich media. The answer to this question came with the direct implication of the E. coli global regulator FIS in aggR activation. FIS, which is itself strongly growth phase dependent, binds to a promoter upstream region close to or overlapping that of AggR, and FIS mutants, which do not contact RNA polymerase, are not able to activate aggR expression. Thus, though AggR may initiate a positive feedback loop amplifying its own expression, the requirement for FIS in a putative nucleoprotein‐activating complex at the aggR promoter constrains the positive feedback loop. The absolute requirement for AggR in its expression also suggests that some degree of promoter leakiness must be tolerated. Our data show that basal levels of aggR expression may be controlled by the repressive actions of the nucleoid‐associated protein H‐NS acting upstream of the aggR promoter. Thus, the aggR promoter is subject to a regulatory scheme that assures its rapid and abundant expression shortly after entering the gastrointestinal tract.

Summary and Conclusions

EAEC has emerged as an important pathogen causing diarrheal disease in multiple epidemiologic and clinical settings. Strain heterogeneity has impeded recognition of this pathogen for many years, but pathogenesis studies are illuminating virulence factors and an unusual degree of heterogeneity among strains in their carriage of putative virulence factors. Better understanding of the roles of individual factors, and of the possibility that different factors could confer distinct clinical presentations, will provide further insights into the true contribution of EAEC as a human pathogen.

References

Al‐Hasani
K
Rajakumar
K
Bulach
D
Robins‐Browne
R
Adler
B
Sakellaris
H
(
2001
)
Genetic organization of the she pathogenicity island in Shigella flexneri 2a
.
Microb Pathogen
 
30
:
1
8
.
Baudry
B
Savarino
SJ
Vial
P
Kaper
JB
Levine
MM
(
1990
)
A sensitive and specific DNA probe to identify enteroaggregative Escherichia coli, a recently discovered diarrheal pathogen
.
J Infect Dis
 
161
:
1249
1251
.
Bernier
C
Le Bouguenec
CC
(
2002
) The AggB and Agg3B proteins produced by enteroaggregative Escherichia coli are two distinct invasins of the AfaD family. ASM 102nd General Meeting, Salt Lake City, Utah.
Bernier
C
Gounon
P
Le Bouguenec
C
(
2002
)
Identification of an aggregative adhesion fimbriae (AAF) type III‐encoding operon in enteroaggregative Escherichia coli as a sensitive probe for detecting the AAF‐encoding operon family
.
Infect Immun
 
70
:
4302
4311
.
Bilge
SS
Clausen
CR
Lau
W
Moseley
SL
(
1989
)
Molecular characterization of a fimbrial adhesin, F1845, mediating diffuse adherence of diarrhea‐associated Escherichia coli to HEp‐2 cells
.
J Bacteriol
 
171
:
4281
4289
.
Canizalez‐Roman
A
Navarro‐Garcia
F
(
2003
)
Fodrin CaM‐binding domain cleavage by Pet from enteroaggregative Escherichia coli leads to actin cytoskeletal disruption
.
Mol Microbiol
 
48
:
947
958
.
Cota
E
Chen
HA
Anderson
KL
, et al. (
2004
)
Complete resonance assignments of the ‘donor‐strand complemented’ AfaD
:
the afimbrial invasin from diffusely adherent E. coli
 . J Biomol Nucl Magn Reson
29
:
411
412
.
Czeczulin
JR
Balepur
S
Hicks
S
, et al. (
1997
)
Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli
.
Infect Immun
 
65
:
4135
4145
.
Czeczulin
JR
Whittam
TS
Henderson
IR
Navarro‐Garcia
F
Nataro
JP
(
1999
)
Phylogenetic analysis of enteroaggregative and diffusely adherent Escherichia coli
.
Infect Immun
 
67
:
2692
2699
.
Elias
WP
Jr
Czeczulin
JR
Henderson
IR
Trabulsi
LR
Nataro
JP
(
1999
)
Organization of biogenesis genes for aggregative adherence fimbria II defines a virulence gene cluster in enteroaggregative Escherichia coli
.
J Bacteriol
 
181
:
1779
1785
.
Eslava
C
Navarro‐Garcia
F
Czeczulin
JR
Henderson
IR
Cravioto
A
Nataro
JP
(
1998
)
Pet, an autotransporter enterotoxin from enteroaggregative Escherichia coli
.
Infect Immun
 
66
:
3155
3163
.
Fasano
A
Noriega
FR
Maneval
DR
Jr
, et al. (
1995
)
Shigella enterotoxin 1
:
an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro
 . J Clin Invest
95
:
2853
2861
.
Fasano
A
Noriega
FR
Liao
FM
Wang
W
Levine
MM
(
1997
)
Effect of Shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo
.
Gut
 
40
:
505
511
.
Folkesson
A
Lofdahl
S
Normark
S
(
2002
)
The Salmonella enterica subspecies I specific centisome 7 genomic island encodes novel protein families present in bacteria living in close contact with eukaryotic cells
.
Res Microbiol
 
153
:
537
545
.
Germani
Y
Minsssart
P
Vohito
M
, et al. (
1998
)
Etiologies of acute, persistent, and dysenteric diarrheas in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus
.
Am J Trop Med Hyg
 
59
:
1008
1014
.
Greenberg
DE
Jiang
Z
Steffen
R
Verenker
MP
DuPont
HL
(
2002
)
Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity
.
J Infect Dis
 
185
:
944
949
.
Harrington
SM
Strauman
MC
Abe
CM
Nataro
JP
(
2005
)
Aggregative adhrence fimbriae contribute to the inflammatory response of epithelial cells infected with enteroaggregative Escherichia coli
.
Cell Microbiol
 
7
:
1565
1578
.
Hayashi
F
Smith
KD
Ozinsky
A
, et al. (
2001
)
The innate immune response to bacterial flagellin is mediated by Toll‐like receptor 5
.
Nature
 
410
:
1099
1103
.
Heimer
SR
Rasko
DA
Lackatell
CV
Johnson
DE
Mobley
HLT
(
2004
)
Autotransporter genes pic and tsh are associated with Escherichia coli strains that cause acute pyelonephritis and are expressed during urinary tract infection
.
Infect Immun
 
72
:
593
597
.
Henderson
IR
Navarro‐Garcia
F
Nataro
JP
(
1998
)
The great escape: structure and function of the autotransporter proteins
.
Trends Microbiol
 
6
:
370
378
.
Henderson
IR
Czeczulin
J
Eslava
C
Noriega
F
Nataro
JP
(
1999a
)
Characterization of Pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli
.
Infect Immun
 
67
:
5587
5596
.
Henderson
IR
Hicks
S
Navarro‐Garcia
F
Elias
WP
Philips
AD
Nataro
JP
(
1999b
)
Involvement of the enteroaggregative Escherichia coli plasmid‐encoded toxin in causing human intestinal damage
.
Infect Immun
 
67
:
5338
5344
.
Hicks
S
Candy
C
Phillips
A
(
1996
)
Adhesion of enteroaggregative Escherichia coli to pediatric intestinal mucosa in vitro
.
Infect Immun
 
64
:
4751
5760
.
Huang
DB
DuPont
HL
(
2004
)
Enteroaggregative Escherichia coli an emerging pathogen in children
.
Semin Pediatr Infect Dis
 
15
:
266
271
.
Huang
DB
DuPont
HL
Jiang
Z
Carlin
L
Okhuysen
PC
(
2004
)
Interleukin‐8 response in an intestinal HCT‐8 cell line infected with enteroaggregative and enterotoxigenic Escherichia coli
.
Clin Diagn Lab Immunol
 
11
:
548
551
.
Huang
DB
Okhuysen
PC
Jiang
ZD
DuPont
HL
(
2004
)
Enteroaggregative Escherichia coli
:
an emerging enteric pathogen
 . Am J Gastroenterol
99
:
383
389
.
Huppertz
H
Rutkowski
S
Aleksic
S
Karch
H
(
1997
)
Acute and chronic diarrhoea and abdominal colic associated with enteroaggregative Escherichia coli in young children living in western Europe
.
Lancet
 
349
:
1660
1662
.
Jiang
Z
Greenberg
D
Nataro
JP
Steffen
R
DuPont
HL
(
2002
)
Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers
.
J Clin Microbiol
 
40
:
4185
4190
.
Kaper
JB
Nataro
JP
Mobley
HLT
(
2004
)
Pathogenic Escherichia coli
.
Nat Rev Microbiol
 
2
:
123
140
.
Knutton
S
Shaw
RK
Bhan
MK
, et al. (
1992
)
Ability of enteroaggregative Escherichia coli strains to adhere in vitro to human intestinal mucosa
.
Infect Immun
 
60
:
2083
2091
.
Monteiro‐Neto
V
Bando
S
Moreira‐Filho
CA
Giron
JA
(
2003
)
Characterization of an outer membrane protein associated with haemagglutination and adhesive properties of enteroaggregative Escherichia coli 0111:H12
.
Cell Microbiol
 
5
:
533
547
.
Nataro
JP
Kaper
JB
Robins‐Browne
R
Prado
V
Vial
P
Levine
MM
(
1987
)
Patterns of adherence of diarrheagenic Escherichia coli to HEp‐2 cells
.
Pediatr Infect Dis J
 
6
:
829
831
.
Nataro
JP
Deng
Y
Maneval
DR
German
AL
Martin
WC
Levine
MM
(
1992
)
Aggregative adherence fimbriae I of enteroaggregative Escherichia coli mediate adherence to HEp‐2 cells and hemagglutination of human erythrocytes
.
Infect Immun
 
60
:
2297
2304
.
Nataro
JP
Yikang
D
Yingkang
D
Walker
K
(
1994
)
AggR, a transcriptional activator of aggregative adherence fimbria I expression in enteroaggregative Escherichia coli
.
J Bacteriol
 
176
:
4691
4699
.
Nataro
JP
Yikang
D
Cookson
S
, et al. (
1995
)
Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers
.
J Infect Dis
 
171
:
465
468
.
Nataro
JP
Hicks
S
Phillips
AD
Vial
PA
Sears
CL
(
1996
)
T84 cells in culture as a model for enteroaggregative Escherichia coli pathogenesis
.
Infect Immun
 
64
:
4761
4768
.
Navarro‐Garcia
F
Eslava
C
Villaseca
JM
, et al. (
1998
)
In vitro effects of a high‐molecular‐weight heat‐labile enterotoxin from enteroaggregative Esherichia coli
.
Infect Immun
 
66
:
3149
3154
.
Nishi
J
Sheikh
J
Mizuguchi
K
, et al. (
2003
)
The export of coat protein from enteroaggregative Escherichia coli by a specific ATP‐binding cassette transporter system
.
J Biol Chem
 
278
:
45680
45689
.
Noriega
FR
Ming Liao
F
Formal
SB
Fasano
A
Levine
MM
(
1995
)
Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes
.
J Infect Dis
 
172
:
1408
1410
.
Okeke
IN
Nataro
JP
(
2001
)
Enteroaggregative Escherichia coli
.
Lancet
 
1
:
304
313
.
Okeke
IN
Lamikanra
A
Czeczulin
J
Dubovsky
F
Kaper
JB
Nataro
JP
(
2000
)
Heterogeneous virulence of enteroaggregative Escherichia coli strains isolated from children in southwest Nigeria
.
J Infect Dis
 
181
:
252
260
.
Okeke
IN
Oladipupo
O
Adebayo
L
Kaper
JB
(
2003
)
Etiology of acute diarrhea in adults in southwestern Nigeria
.
J Clin Microbiol
 
41
:
4525
4530
.
Piva
IC
Pereira
AL
Ferraz
LR
, et al. (
2003
)
Virulence markers of enteroaggregative Escherichia coli isolated from children and adults with diarrhea in Brasilia, Brazil
.
J Clin Microbiol
 
41
:
1827
1832
.
Plancon
L
Du Merle
L
Le Friec
S
Gounon
P
Jouve
M
Guignot
J
(
2003
)
Recognition of the cellular β1‐chain integrin by the bacterial AfaD invasin is implicated in the internalization of afa‐expressing pathogenic Escherichia coli strains
.
Cell Microbiol
 
5
:
681
693
.
Rao
PS
Yamada
Y
Tan
YP
Leung
KY
(
2004
)
Use of proteomics to identify novel virulence determinants that are required for Edwardsiella tarda pathogenesis
.
Mol Microbiol
 
53
:
573
586
.
Sarantuya
J
Nishi
J
Wakimoto
N
, et al. (
2004
)
Typical enteroaggregative Escherichia coli is the most prevalent pathotype among E. coli strains causing diarrhea in Mongolian children
.
J Clin Microbiol
 
42
:
133
139
.
Savarino
SJ
Fasano
A
Watson
J
, et al. (
1993
)
Enteroaggregative Escherichia coli heat‐stable enterotoxin 1 represents another subfamily of E. coli heat‐stable toxin
.
Proc Natl Acad Sci USA
 
90
:
3093
3097
.
Savarino
SJ
Fox
P
Yikang
D
Nataro
JP
(
1994
)
Identification and characterization of a gene cluster mediating enteroaggregative adherence fimbriae I biogenesis
.
J Bacteriol
 
176
:
4949
4957
.
Savarino
SJ
McVeigh
A
Watson
J
, et al. (
1995
)
Enteroaggregative Escherichia coli heat‐stable enterotoxin is not restricted to enteroaggregative E. coli
.
J Infect Dis
 
173
:
1019
1022
.
Schubert
S
Rakin
A
Karch
H
Carniel
E
Hessemeann
J
(
1998
)
Prevalence of the ‘High‐Pathogenicity Island’ of Yersinia species among Escherichia coli strains that are pathogenic to humans
.
Infect Immun
 
66
:
480
485
.
Sheikh
J
Czeczulin
JR
Harrington
S
, et al. (
2002
)
A novel dispersin protein in enteroaggregative Escherichia coli
.
J Clin Invest
 
110
:
1329
1337
.
Steiner
TS
Lima
AAM
Nataro
JP
Guerrant
RL
(
1998
)
Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin‐8 release from intestinal epithelial cells
.
J Infect Dis
 
177
:
88
96
.
Steiner
TS
Nataro
JP
Poteet‐Smith
CE
Smith
JA
Guerrant
RL
(
2000
)
Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL‐8 release from intestinal epithelial cells
.
J Clin Invest
 
105
:
1769
1777
.
Tzipori
S
Montanaro
J
Robins‐Browne
RM
Vial
P
Gibson
R
Levine
MM
(
1992
)
Studies with enteroaggregative Escherichia coli in the gnotobiotic piglet gastroenteritis model
.
Infect Immun
 
60
:
5302
5306
.
Vial
PA
Robins‐Browne
R
Lior
H
, et al. (
1988
)
Characterization of enteroadherent‐aggregative Escherichia coli, a putative agent of diarrheal disease
.
J Infect Dis
 
158
:
70
79
.
Vila
J
Vargas
M
Henderson
IR
Gascon
J
Nataro
JP
(
2000
)
Enteroaggregative Escherichia coli virulence factors in traveler's diarrhea strains
.
J Infect Dis
 
182
:
1780
1783
.
Villaseca
JM
Navarro‐Garcia
F
Mendoza‐Hernandez
G
Nataro
JP
Cravioto
A
Eslava
C
(
2000
)
Pet toxin from enteroaggregative Escherichia coli produces cellular damage associated with fodrin disruption
.
Infect Immun
 
68
:
5920
5927
.
Wilson
A
Evans
J
Chart
H
, et al. (
2001
)
Characterization of strains of enteroaggregative Escherichia coli isolated during the infectious intestinal disease study in England
.
Eur J Epidemiol
 
17
:
1125
1130
.
Zhou
Z
Ogasawara
J
Nishikawa
Y
, et al. (
2002
)
An outbreak of gastroenteritis in Osaka, Japan due to Escherichia coli serogroup O166:H15 that had a coding gene for enteroaggregative E. coli heat‐stable enterotoxin 1 (EAST1)
.
Epidemiol Infect
 
128
:
363
371
.

Author notes

Current address coauthor: Susan M. Harrington, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.